Manhattan Scientifics, Inc. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was USD 50,000 compared to USD 97,000 a year ago. Operating loss was USD 675,000 compared to USD 1.025 million a year ago. Net income was USD 4.314 million compared to net loss of USD 1.222 million a year ago. Basic earnings per share from continuing operations was USD 0.01.